## Abstract ## BACKGROUND Approximately 20β30% of patients with acute promyelocytic leukemia (APL) who are treated with allβ__trans__ retinoic acid (ATRA) and an anthracycline develop recurrent disease. It has been reported that arsenic trioxide (As~2~O~3~) is effective in this setting. The author
Use of calf thymosin F-5 in the treatment of 12 cases of leukemia complicated with acute infection
β Scribed by X.Y. Zhao; C.X. Zheng; S.L. Liu
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- English
- Weight
- 52 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Pulmonary and cerebral leukostasis, or parenchymal hemorrhage in these organs, are well-known early complications developing in patients with acute myeloid leukemia (aml), particularly when myelomonocytic features, hyperleukocytosis, and/or a coagulation disorder are initially presen
Neurologic complications, including both the acute and chronic forms of inflammatory demyelinating polyradiculoneuropathy (IDP) are becoming more prevalent among patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related-complex (ARC). Although the etiology of the above radiculoneu
The most effective schedule of cytosine arabinoside (Ara-C) administration remains controversial and is further confused by the use of combination chemotherapy. Two remission induction regimens comprising adriamycin, Ara-C, and 6-thioguanine have been compared in patients with acute myelogenous leuk